Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hanna van Ooijen"'
Autor:
Shuo Li, Bin Zhang, Jeffrey S Miller, Veronika Kremer, Bahram Valamehr, Frank Cichocki, Martin Felices, Karl-Johan Malmberg, Hans-Gustaf Ljunggren, Björn Önfelt, Laura Bendzick, Evren Alici, Alvaro Haroun-Izquierdo, Marianna Vincenti, Herman Netskar, Hanna van Ooijen, Minoru Kanaya, Pouria Momayyezi, Merete Thune Wiiger, Hanna Julie Hoel, Silje Zandstra Krokeide, Geir Tjonnfjord, Stéphanie Berggren, Kristina Wikström, Pontus Blomberg, Petter Höglund, Andreas Björklund, Quirin Hammer, Lise Kveberg, Ebba Sohlberg
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Background Natural killer (NK) cells hold great promise as a source for allogeneic cell therapy against hematological malignancies, including acute myeloid leukemia (AML). Current treatments are hampered by variability in NK cell subset responses, a
Externí odkaz:
https://doaj.org/article/8258a4c676844cf5b29d48819f8eb9c2
Autor:
Alvaro, Haroun-Izquierdo, Marianna, Vincenti, Herman, Netskar, Hanna, van Ooijen, Bin, Zhang, Laura, Bendzick, Minoru, Kanaya, Pouria, Momayyezi, Shuo, Li, Merete Thune, Wiiger, Hanna Julie, Hoel, Silje Zandstra, Krokeide, Veronika, Kremer, Geir, Tjonnfjord, Stéphanie, Berggren, Kristina, Wikström, Pontus, Blomberg, Evren, Alici, Martin, Felices, Björn, Önfelt, Petter, Höglund, Bahram, Valamehr, Hans-Gustaf, Ljunggren, Andreas, Björklund, Quirin, Hammer, Lise, Kveberg, Frank, Cichocki, Jeffrey S, Miller, Karl-Johan, Malmberg, Ebba, Sohlberg
Publikováno v:
Journal for immunotherapy of cancer. 10(11)
Natural killer (NK) cells hold great promise as a source for allogeneic cell therapy against hematological malignancies, including acute myeloid leukemia (AML). Current treatments are hampered by variability in NK cell subset responses, a limitation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a5200874cfec00a15fc63e540892f8ac
https://pubmed.ncbi.nlm.nih.gov/36319065
https://pubmed.ncbi.nlm.nih.gov/36319065
Autor:
Valentina Carannante, Niklas Sandström, Karl Olofsson, Shi Yong Neo, Patrick Albert Sandoz, Hanna Van Ooijen, Quentin Verron, Jacopo Fontana, Damien Toullec, Elisabeth Moussaud-Lamodière, Brinton Seashore-Ludlow, Thomas Frisk, Madoka Takai, Päivi Östling, Felix Haglund, Andreas Lundqvist, Martin Wiklund, Björn Önfelt
Publikováno v:
Cancer Research. 83:4578-4578
Tumor diversity and rarity of patient tumor material negatively contribute to the development of new effective treatments for sarcomas. As a high proportion of sarcoma patients presents inherent or acquired chemo-resistance, immune checkpoint inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf1108aca84b3b5890cf391b0cb14612
https://doi.org/10.1158/1538-7445.am2023-4578
https://doi.org/10.1158/1538-7445.am2023-4578
Autor:
Quirin Hammer, Karlo Perica, Rina M Mbofung, Hanna van Ooijen, Erika Varady, Mark Jelcic, Yijia Pan, Pouria Momayyezi, Brian Groff, Ramzey Abujarour, Silje Zandstra Krokeide, Tom Lee, Alan M Williams, Jode P Goodridge, Bahram Valamehr, Bjorn Onfelt, Michel Sadelain, Karl-Johan Malmberg
Publikováno v:
Blood. 140:1165-1166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b47f55ee5682424142ab742198c31c6
https://doi.org/10.1182/blood-2022-163086
https://doi.org/10.1182/blood-2022-163086
Autor:
Niklas, Sandström, Valentina, Carannante, Karl, Olofsson, Patrick A, Sandoz, Elisabeth L, Moussaud-Lamodière, Brinton, Seashore-Ludlow, Hanna, Van Ooijen, Quentin, Verron, Thomas, Frisk, Madoka, Takai, Martin, Wiklund, Päivi, Östling, Björn, Önfelt
Publikováno v:
Cell reports methods. 2(7)
Here, we present a methodology based on multiplexed fluorescence screening of two- or three-dimensional cell cultures in a newly designed multichambered microwell chip, allowing direct assessment of drug or immune cell cytotoxic efficacy. We establis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0fc9a4ceaf67a8fe8692fe0aa5c6cd71
https://pubmed.ncbi.nlm.nih.gov/35880015
https://pubmed.ncbi.nlm.nih.gov/35880015
Autor:
Björn Önfelt, Isabel Prager, Niklas Sandström, Clarissa Liesche, Quentin Verron, Hanna van Ooijen, Doris Urlaub, Roland Eils, Frank Fasbender, Maren Claus, Joël Beaudouin, Carsten Watzl
Publikováno v:
The Journal of Experimental Medicine
Natural killer cells can kill infected and transformed cells via two different cell death mechanisms. Prager et al. show that NK cells quickly kill their first targets by releasing cytotoxic granules and only use the slower death receptor–mediated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd61f5d28f67a893d2488f56f7b9af7
https://pubmed.ncbi.nlm.nih.gov/31270246
https://pubmed.ncbi.nlm.nih.gov/31270246
Autor:
Karl-Johan Malmberg, Jeffrey S. Miller, Sarah Cooley, Eivind Heggernes Ask, Ebba Sohlberg, Eva Hellström-Lindberg, Merete Thune Wiiger, Andreas T. Björklund, Michael Chrobook, Bahram Valamehr, Evren Alici, Alvaro Haroun-Izquierdo, Karolin Guldevall, Hanna van Ooijen, Veronika Kremer, Hans-Gustaf Ljunggren, Hanna Julie Hoel, Björn Önfelt, Jodie P. Goodridge, Blomberg Pontus, Aline Pfefferle
Publikováno v:
Blood. 132:195-195
Natural killer (NK) cells hold great promise as a source for allogeneic cell therapy against hematological malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). NK cell recognition of allogeneic tumors is strictly r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8f41c8662e500fef05067501830f712
https://doi.org/10.1182/blood-2018-195
https://doi.org/10.1182/blood-2018-195